ArticleCancer research and treatment2022

Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma.

Ji Won Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.